MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Wadsworth Medical, Westborough, Mass.
Wadsworth’s DermaLOC is a needle-free acute wound closure disposable.
Officers
Andrew Fox, Founder & President
Product
DermaLoc is a rapid, needle-less and durable wound closure disposable targeted at the multi-billion dollar acute wound closure industry. DermaLoc leverages its proprietary technology to transform and simplify how healthcare providers close lacerations and incisions. DermaLoc is faster, produces better cosmetic results, and is more cost-effective than existing or emerging technologies. Adhesives and tapes are messy and reserved for tiny incisions. DermaLOC matches or exceeds all the benefits of sutures, staples, glue and strips and is not associated with any of the negative consequences of all other current alternatives. DermaLOC value propositions include:
- Reduced wound closure time by 90%
- Improved cosmetic result
- Minimized pain; no anesthesia or sedation
- Existing reimbursement
- Ease of use on most types and sizes of wound
- No transition costs
- No sharps
